Skip to content
Home/Companies/Biotech/Pretzel Therapeutics
PT

Pretzel Therapeutics

Biotech·USA·Active·4yr hold

Pretzel Therapeutics is a biotech company, headquartered in USA.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Pretzel Therapeutics?

Pretzel Therapeutics is currently owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage), since 2022.

Hand-verified · updated 2026-06-21

Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund II · 2022 · VC

Key facts

HQUSA
SectorBiotech
StatusActive

More from CIC Fund II

Other portfolio companies in the same fund.

Immutrin
Active
BiotechUK· 2025
TRIMTECH Therapeutics
Active
BiotechUK· 2025
Forefront RF
Active
TelecomUK· 2024
Nuclera
Active
BiotechUnited Kingdom· 2024
Complement Therapeutics
Active
BiotechUK· 2023
Mosaic TX
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings